BASIS-TECHNOLOGIES
28.4.2016 14:03:46 CEST | Business Wire | Press release
Basis Technologies today announces the introduction of Consolidator, a new addition to its extensive range of automation tools. Consolidator performs the technical analysis and merge of SAP ECC systems, including those running on HANA, with minimal user intervention. Automation reduces the risk and cost of the overall process, allowing more businesses to realize the benefits of SAP system consolidation.
A time of change
Sixty-four percent of IT and marketing executives recently surveyed by Gartner said that they expect to transform into a digital business by the end of 20171 .
In such a dynamic, disruptive environment, business initiatives like digital transformation are becoming commonplace. A shift to cloud-based Enterprise Resource Planning (ERP) solutions, including S/4HANA from SAP, is also underway, and M&A activity continues to gather pace. Meanwhile, potentially huge opportunities lurk inside inefficient SAP system landscapes built up over decades of acquisitions and reorganizations.
All of these factors are combining to generate an ever-increasing level of demand for SAP system consolidation projects.
A new way to unlock value
To date, a limited number of tools have been available to support system consolidation. This has resulted in processes which feature an unavoidably high level of manual effort, with the corresponding business risk that such methods naturally bring.
Consolidator offers the chance to automate a critical - and labor-intensive - portion of the consolidation process: the technical merge. Risk and necessary resource inputs are dramatically reduced, enabling businesses to unlock value, focus on innovation, reduce cost of ownership and prepare for a new generation of enterprise solutions.
"Businesses should give more thought to optimization of the SAP systems that enable great customer experiences. Too much cash is being wasted on simply maintaining existing processes and stabilizing legacy infrastructure." said Martin Metcalf, Chief Executive Officer of Basis Technologies. "There is just not enough focus placed on unlocking the latent value within these assets through the use of automation technologies such as Consolidator"
To learn more about Consolidator, visit www.basistechnologies.com/consolidator
About Basis Technologies
Basis Technologies have delivered innovative software solutions for SAP for almost 20 years. We focus on automation tools that enable continuous delivery, helping our customers to keep pace with theirs. Our products support the adoption of methodologies such as Agile and DevOps in an SAP environment, and our client list includes a selection of major multinational companies such as BP, Unilever and Ralph Lauren.
To find out more, visit www.basistechnologies.com .
####
1. Navigate Your Way to Digital Business Transformation With These Resources, Don Scheibenreif, VP Distinguished Analyst, Gartner (August 2015)
2. Consolidator does not support the analysis or merge of transactional or master data. Other tools may be required.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160428005020/en/
Contact:
Basis Technologies
Peter Yabsley
Head of Product Marketing
+44
7867 335 310
peter.yabsley@basistechnologies.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom